Provided by Tiger Fintech (Singapore) Pte. Ltd.

Astria Therapeutics Inc

5.12
+0.16003.23%
Pre-market: 5.310.1900+3.71%08:00 EDT
Volume:327.71K
Turnover:1.68M
Market Cap:288.94M
PE:-3.05
High:5.19
Open:5.06
Low:5.02
Close:4.96
Loading ...
Jan 07, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 15, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 23, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 22, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 08, 2021

Major Issues Report

8-K - Current report
Aug 20, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 30, 2021

Major Issues Report

8-K - Current report
Jun 25, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 25, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 17, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 17, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 15, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 10, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jun 02, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]